Identification of Candida dubliniensis based on temperature and utilization of xylose and α-methyl-D-glucoside as determined with the API 20C AUX and Vitek YBC systems

Journal of Clinical Microbiology

Volumn 37, Issue 12, 1999, Pages 3804-3808

  Gales, A C ^a,b   Pfaller, M A ^a   Houston, A K ^a   Joly, S ^c   Sullivan, D J ^d   Coleman, D C ^d   Soll, D R ^c  

^a UNIVERSITY OF IOWA   (United States)

^b FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

^c UNIVERSITY OF IOWA   (United States)

^d TRINITY COLLEGE DUBLIN   (Ireland)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA METHYLGLUCOSIDE; XYLOSE;

ARTICLE; CANDIDA ALBICANS; CANDIDA DUBLINIENSIS; CANDIDIASIS; FUNGUS CULTURE; FUNGUS GROWTH; MOUTH FLORA; NONHUMAN; PRIORITY JOURNAL;

CANDIDA ALBICANS; CANDIDA DUBLINIENSIS; FUNGI;

EID: 0032752659     PISSN: 00951137     EISSN: None     Source Type: Journal    
DOI: 10.1128/jcm.37.12.3804-3808.1999     Document Type: Article

References (24)

1. Bikandi, J., R. S. Millan, M. D. Moragues, G. Cebas, M. Clarke, D. C. Coleman, D. J. Sullivan, G. Quindos, and J. Ponton. 1998. Rapid identification of Candida dubliniensis by indirect immunofluorescence based on differential localization of antigens on C. dubliniensis blastospores and Candida albicans germ tubes. J. Clin. Microbiol. 36:2428-2433.
2. Bueshing, W. J., K. Kurek, and G. D. Roberts. 1979. Evaluation of the modified AP120C systems for identification of clinically important yeasts. J. Clin. Microbiol. 9:565-569.
3. Coleman, D. C., M. G. Rinaldi, K. A. Haynes, J. H. Rex, R. C. Summerbell, E. J. Anaissie, A. Li, and D. J. Sullivan. 1998. Importance of Candida species other than Candida albicans as opportunistic pathogens. Med. Mycol. 36(Suppl. 1):156-165.
4. Coleman, D. C., D. J. Sullivan, D. E. Bennett, G. P. Moran, H. J. Barry, and D. B. Shanley. 1997. Candidiasis: the emergence of a novel species, Candida dubliniensis. AIDS 11:557-567.
5. Jabra-Rizk, M. A., A. A. M. A. Baqui, J. I. Kelley, W. A. Falkler Jr, W. G. Merz, and T. F. Meiller. 1999. Identification of Candida dubliniensis in a prospective study of patients in the United States. J. Clin. Microbiol. 37: 321-326.
6. Joly, S., C. Pujol, M. Rysz, K. Vargas, and D. R. Soll. 1999. Development and characterization of complex DNA fingerprinting probes for the infectious yeast Candida dubliniensis. J. Clin. Microbiol. 37:1035-1044.
7. Kirkpatrick, W. R., S. G. Revankar, R. K. Meatee, J. L. Lopez-Ribot, A. W. Fothergill, D. I. McCarthy, S. E. Sanche, R. A. Cantu, M. G. Rinaldi, and T. F. Patterson. 1998. Detection of Candida dubliniensis in oropharyngeal samples from human immunodeficiency virus-infected patients in North America by primary CHROMagar Candida screening and susceptibility testing of isolates. J. Clin. Microbiol. 36:3007-3012.
8. Koehler, A. P., K. C. Chu, E. T. S. Houang, and A. F. B. Cheng. 1999. Simple, reliable, and cost-effective yeast identification scheme for clinical laboratory. J. Clin. Microbiol. 37:422-426.
9. Meis, J. F., M. Ruhnke, B. E. De Pauw, F. C. Odds, W. Siegert, and P. E. Verweij. 1999. Candida dubliniensis candidemia in patients with chemotherapy-induced neutropenia and bone marrow transplantation. Emerg. Infect. Dis. 5:150-153.
10. Minamoto, G. Y., and A. S. Rosenberg. 1997. Fungal infections in patients with acquired immunodeficiency syndrome. Med. Clin. North Am. 81:381-409.
11. Moran, G. P., D. J. Sullivan, M. C. Henman, C. E. McCreary, B. J. Barrington, D. B. Shanley, and D. C. Coleman. 1997. Antifungal drug susceptibilities of oral Candida dubliniensis isolates from human immunodeficiency virus (HIV)-infected and non-HIV-infected subjects and generation of stable fluconazole-resistant derivatives in vitro. Antimicrob. Agents Chemother. 41:617-623.
12. Moran, G. P., D. Sanglard, S. M. Donnelly, D. B. Shanley, D. J. Sullivan, and D. C. Coleman. 1998. Identification and expression of multidrug transporters responsible for fluconazole resistance in Candida dubliniensis. Antimicrob. Agents Chemother. 42:1819-1830.
13. Odds, F. C., L. Van Nuffel, and G. Dams. 1998. Prevalence of Candida dubliniensis isolates in a yeast stock collection. J. Clin. Microbiol. 36:2869- 2873.
14. Pfaller, M. A. 1994. Epidemiology and control of fungal infections. Clin. Infect. Dis. 19(Suppl. 1):S8-S13.
15. Pfaller, M. A., S. R. Lockhart, C. Pujol, J. A. Swails-Wenger, S. A. Messer, M. E. Edmond, R. N. Jones, R. P. Wenzel, and D. R. Soll. 1998. Hospital specificity, region specificity, and fluconazole resistance of Candida albicans bloodstream isolates. J. Clin. Microbiol. 36:1518-1529.
16. Pfaller, M. A., S. A. Messer, S. Gee, S. Joly, C. Pujol, D. J. Sullivan, D. C. Coleman, and D. K. Soll. 1999. In vitro susceptibilities of Candida dubliniensis isolates tested against the new triazole and echinocandin antifungal agents. J. Clin. Microbiol. 37:870-872.
17. Pinjon, E., D. J. Sullivan, I. F. Salkin, D. Shanley, and D. C. Coleman. 1998. Simple, inexpensive, reliable method for differentiation of Candida dubliniensis from Candida albicans. J. Clin. Microbiol. 36:2093-2095.
18. Salkin, I. F., W. R. Pruitt, A. A. Padhye, D. J. Sullivan, D. C. Coleman, and D. H. Pincus. 1998. Distinctive carbohydrate assimilation profiles used to identify the first clinical isolates of Candida dubliniensis recovered in the United States. J. Clin. Microbiol. 36:1467.
19. Schoofs, A., F. C. Odds, R. Colebunders, M. Leven, and H. Goossens. 1997. Use of specialized isolation media for recognition and identification of Candida dubliniensis isolates from HIV-infected patients. Eur. J. Clin. Microbiol. Infect. Dis. 16:296-300.
20. Sullivan, D. J., and D. C. Coleman. 1998. Candida dubliniensis: characteristics and identification. J. Clin. Microbiol. 36:329-334.
21. Sullivan, D. J., K. Haynes, J. Bille, P. Boerlin, L. Rodero, S. Lloyd, M. Henman, and D. C. Coleman. 1997. Widespread geographic distribution of oral Candida dubliniensis strains in human immunodeficiency virus-infected individuals. J. Clin. Microbiol. 35:960-964.
22. Sullivan, D. J., T. J. Westerneng, K. A. Haynes, D. E. Bennett, and D. C. Coleman. 1995. Candida dubliniensis sp. nov.: phenotypic and molecular characterization of a novel species associated with oral candidiasis in HIV-infected individuals. Microbiology 141:1507-1521.
23. Wingard, J. R. 1995. Importance of Candida species other than Candida albicans as pathogen in oncology patients. Clin. Infect. Dis. 20:115-125.
24. Wingard, J. R., W. G. Merz, M. G. Rinaldi, T. R. Johnson, J. E. Karp, and R. Saral. 1991. Increase in Candida krusei infection among patients with bone marrow transplantation and neutropenia treated prophylactically with fluconazole. N. Engl. J. Med. 325:1274-1277.